Abstract
Abstract Background: Increased access to ART to key populations who bear a disproportionate burden of HIV, including female sex workers, provides a great opportunity to reduce onward transmission. This is however dependent on achieving high levels of adherence to ART. We set out to determine level of adherence to ART and associated factors among female sex workers in Uganda. Methods: In this cross-sectional study between May and June 2017, we consecutively enrolled 226 female sex workers accessing HIV care at an urban clinic in Kampala, Uganda. We assessed self-reported adherence using interviewer administered questionnaires and reviewing medical records. We defined high level adherence as those who scored ≥95% at assessment. Using multivariable logistic regression, we identified factors independently associated with adherence. Results: Overall, 59.2 % of participants were adherent to ART. Major reasons for non-adherence were being away from home (40.8%) and forgetfulness (26.7%). In the multivariable model, owning a phone (AOR 2.90; 95% CI 1.07, 7.88), a 10-year increase in age (AOR 1.60; 95% CI 1.00, 2.60) and being a widow (AOR 0.22; 95% CI 0.05, 0.87) were independently associated with adherence. Conclusion: Our study found low observed adherence to ART among female sex workers in Uganda. This baseline assessment builds a case for the development and scale up of targeted intervention strategies to increase to ART adherence among female sex workers. Incorporating information and communication technology such as mobile phones in routine adherence counseling could be scaled up among key populations such as female sex workers. Keywords: Antiretroviral therapy, adherence, female sex workers, information and communication technology, mobile phone.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by IAVI and made possible by the support of many donors including United States Agency for International Development (USAID). The full list of IAVI donors is available at http://www.iavi.org
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Uganda Virus Research Institute Research Ethics Committee (GC/127/14/10/30) and Uganda National Council for Science and Technology (HS 364) gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos